Advertisement
Olysio Coupon - Olysio 28 capsules of 150mg bottle
Olysio
Specialty Drug

Simeprevir

SIMEPREVIR is an antiviral medicine. It is used with other antivirals to treat hepatitis C. It will not work for colds, flu, or other viral infections. Compare hepatitis C protease inhibitors.
Olysio Coupon - Olysio 28 capsules of 150mg bottle

Insurance Coverage: Many major insurance plans no longer cover Olysio starting in 2016. Learn More

Advertisement

Olysio Latest News

Get the latest updates on this drug from the GoodRx medical team

FDA Safety Alert: Direct-Acting Antivirals for Hepatitis C

The GoodRx Pharmacist - November 12, 2016

The FDA has issued a drug safety alert for direct-acting antivirals used to treat Hepatitis C. They warn that using direct-acting antivirals such as Sovaldi, Harvoni, or Zepatier can cause a reactivation of Hepatitis B in patients who have been previously infected with the virus.

The FDA gained knowledge about the reactivation of hepatitis B occurring from direct-acting antivirals through reported incidents and published literature. See More

40+ Drugs to Be Dropped By Insurance

Elizabeth Davis - August 17, 2016

Americans, get ready for sticker shock at the pharmacy.

In 2017, the nation’s largest insurance companies will likely exclude up to 154 different drugs from coverage. If you’re taking one of these prescriptions, your co-pay is about to go way, way up.

Last year, popular drugs including Viagra and Qsymia were dropped by major insurance plans for 2016. The trend continues this year. Almost 50 popular brand-name and generic drugs will likely no longer be covered by one of the nation’s largest prescription insurance providers. See More

Why Are So Many Drug Prices Increasing?

The GoodRx Pharmacist - September 30, 2015

If you’ve been following the news, huge price increases on necessary drugs like Daraprim and cycloserine may seem unusual—they both dropped in price again once people noticed and complained, right?

The unfortunate reality as that price increases happen in the pharmaceutical industry day-in and day-out. While the majority aren’t quite as dramatic as the Daraprim price hike, they happen more often than you might think. See More

50+ Drugs Dropped by Insurance in 2016, Including Viagra and Qsymia

Elizabeth Davis - August 12, 2015

It’s that time again—the new lists of covered and excluded drugs on next year’s insurance plans are out, and it doesn’t look great. For many Americans with health insurance, more than 50 popular brand-name and generic drugs may no longer be covered starting in January 2016.

Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing about 20 – 30 drugs each from their national preferred formularies at the end of 2015. See More

New GoodRx Top 10 Drug Guide

Elizabeth Davis - June 05, 2015

Our new top 10 lists are in for the most-dispensed and most expensive prescriptions in the US—take a look at these interesting updates.

Which prescriptions have been filled the most in 2015 so far?

Based on a sample of claims reported by pharmacies across the country, thyroid meds like Synthroid and levothyroxine near the top of the list, while standard heart and diabetes prescriptions lisinopril (Zestril, Prinivil), atorvastatin (Lipitor), and metformin (Glucophage) are still very frequently prescribed—no surprises there. See More

GoodRx Top 10 Drug Guide

Elizabeth Davis - February 06, 2015

We’ve updated our lists of the Top 10 most-dispensed and most expensive prescriptions in the US, with some interesting changes from the end of 2014.

Curious about the most popular prescriptions?

Based on a sample of claims reported by pharmacies across the country, some common antibiotics, like amoxicillin (Amoxil) and azithromycin (Zithromax) top the list, along with heart meds like atorvastatin (Lipitor) and lisinopril (Zestril, Prinivil). See More

Express Scripts vs Caremark: The Battle for Hepatitis C Coverage

The GoodRx Pharmacist - January 14, 2015

In the past year, the realm of hepatitis C treatment has been flourishing. Several new medications have received FDA approval and have changed the way we treat this often silent disease.

With the introduction of new first line treatments, slowly but surely, we will begin to see the discontinuation of many older hepatitis C treatments. Incivek was pulled by its manufacturer, Vertex Pharmaceuticals, back in October. See More

Viekira Pak: New Hepatitis C Med Now Available

The GoodRx Pharmacist - January 05, 2015

Viekira Pak was approved by the FDA on December 19, 2015 as the newest treatment for chronic hepatitis C (genotype 1), and is already available to patients. Genotype 1 is the most common in the US, affecting around 75% of Americans with the virus.

Were there any special circumstances for the approval of Viekira Pak?

Yes. Viekira Pak was designated a breakthrough therapy. That means the approval process could be completed faster than usual. See More

Harvoni: New Once-Daily Combination for Hepatitis C

The GoodRx Pharmacist - October 20, 2014

The FDA recently approved Harvoni (ledipasvir/sofosbuvir), a new combination oral medication for the treatment of hepatitis C that stops the replication of the virus.

What is Harvoni?
Harvoni 90 mg/400 mg tablets are a once-daily treatment that can be used without injectable pegylated interferon alpha (Pegintron, Pegasys) or oral ribavirin (Copegus, Ribasphere, Rebetol).

Why is Harvoni different from other hepatitis C treatments?
Harvoni is unique because it is the first combination pill approved to treat chronic hepatitis C genotype 1 infection and it DOES NOT require combination treatment with pegylated interferon or ribavirin—medications that use to be first line therapy, but have serious side effects. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.